Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Fibrosis

Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

377 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Fibrosis trial results

Recruiting

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

NCT06968845

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • UAB Lung Health Center Birmingham, Alabama, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Paradigm Clinical Research Centers, LLC San Diego, California, United States
  • National Jewish Health Denver, Colorado, United States
View all 36 locations
View Trial Details
Recruiting

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

NCT07230288

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Sec Clinical Research - East - Dothan - Graceland /ID# 278328 Dothan, Alabama, United States
  • Christie Clinic on University /ID# 277871 Champaign, Illinois, United States
  • Hannibal Regional Hospital /ID# 277984 Hannibal, Missouri, United States
  • Centre d'Investigation Clinique Mauricie /ID# 277949 Trois-Rivières, Quebec, Canada
View all 57 locations
View Trial Details
Recruiting

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

NCT07036523

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Florida Gainesville, Florida, United States
  • Renstar Medical Research Ocala, Florida, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 46 locations
View Trial Details
Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT05571059

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Biosolutions Clinical Research La Mesa, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Miami VA Health System Miami, Florida, United States
View all 20 locations
View Trial Details
Recruiting

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

NCT07671911

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Pulmonary Specialists of The Palm Beaches Loxahatchee Groves, Florida, United States
  • Clinical Research and Associates, Inc. Miami, Florida, United States
  • Clinical Research of Gastonia (CRG) Gastonia, North Carolina, United States
  • El Paso Pulmonary Association, PA El Paso, Texas, United States
View all 15 locations
View Trial Details
Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

NCT06951217

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • Renstar Medical Research Ocala, Florida, United States
View all 72 locations
View Trial Details
Recruiting

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

NCT07002034

Conditions
Adjustment Disorder, Adjustment Disorders, Amyotrophic Lateral Sclerosis, +28 more
Locations
  • UAB, Psychiatry and Behavioral Neurology Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • Kadima Neuropsychiatry Institute San Diego, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
View all 32 locations
View Trial Details

Related conditions